Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index; 1 of the 26 sources its claims cite were checked for support.
Abstract
Purpose: The incidence of esophageal adenocarcinoma (EAC) has risen substantially in recent decades, while the average 5-year survival remains only ~20%. Disease stage and treatment are the strongest prognostic factors. The role of lifestyle factors in relation to survival remains uncertain, with a handful of studies to date investigating associations with obesity, smoking, physical activity, diet, or medications. Methods: This study included patients diagnosed with primary adenocarcinoma of the esophagus, gastroesophageal junction, or cardia (N = 371) at Roswell Park Comprehensive Cancer Center between 2003 and 2019. Leveraging extensive data abstracted from electronic medical records, epidemiologic questionnaires, and a tumor registry, we analyzed clinical, behavioral, and environmental exposures and evaluated stage-specific associations with survival. Survival distributions were visualized using Kaplan–Meier curves. Cox proportional hazards regression models adjusted for age, sex, stage, treatment, and comorbidities were used to estimate the association between each exposure and all-cause or cancer-specific mortality. Results: Among patients presenting with localized/regional tumors (stages I–III), current smoking was associated with increased overall mortality risk (HR = 2.5 [1.42–4.53], p = 0.002), while current physical activity was linked to reduced risk (HR = 0.58 [0.35–0.96], p = 0.035). Among patients with stage IV disease, individuals reporting pre-diagnostic use of statins (HR = 0.62 [0.42–0.92], p = 0.018) or NSAIDs (HR = 0.61 [0.42–0.91], p = 0.016) had improved overall survival. Exploratory analyses suggested that high pre-diagnostic dietary consumption of broccoli, carrots, and fiber correlated with prolonged overall survival in patients with localized/regional disease. Conclusion: Our data suggest that lifestyle exposures may be differentially associated with EAC survival based on disease stage. Future investigation of larger, diverse patient cohorts is essential to validate these findings. Our results may help inform the development of lifestyle-based interventions to improve EAC prognosis and quality of life.
Overview
CoChat Summary
## TL;DR
This retrospective cohort study of 371 esophageal adenocarcinoma patients at Roswell Park found that survival associations differed by stage: current smoking and current inactivity were linked to worse outcomes in localized/regional disease, while pre-diagnostic statin and NSAID use were linked to better survival in stage IV disease. Exploratory analyses also suggested better survival with higher intake of broccoli, carrots, and fiber among localized/regional cases.
## Key findings
- Among patients with localized/regional disease (stage I–III), current smokers had a 2.5-fold higher all-cause mortality risk than never smokers (HR = 2.5, 95% CI 1.42–4.53; p = 0.002).
- In localized/regional disease, current physical activity was associated with lower all-cause mortality risk (HR = 0.58, 95% CI 0.35–0.96; p = 0.035).
- Among stage IV patients, pre-diagnostic statin use was associated with lower all-cause mortality (HR = 0.62, 95% CI 0.42–0.92; p = 0.018), and pre-diagnostic NSAID use was also associated with lower all-cause mortality (HR = 0.61, 95% CI 0.42–0.91; p = 0.016).
- Exploratory dietary analyses in localized/regional disease found reduced all-cause mortality with >3 servings/month of broccoli and carrots, and with >18.6 g/day of fiber; the paper reports 47% and 62% reduced risk for broccoli and carrots, respectively, and 66% reduced risk for higher fiber intake.
## Methods
- Retrospective cohort of 371 patients with newly diagnosed histologically confirmed primary adenocarcinoma of the esophagus, gastroesophageal junction, or cardia, treated at Roswell Park Comprehensive Cancer Center; participants enrolled in the DBBR between January 2003 and September 2019.
- Data came from electronic medical records, the Roswell Park Tumor Registry, and DBBR questionnaires; outcomes were all-cause survival and esophageal cancer-specific survival through September 2019.
- Kaplan–Meier curves and Cox proportional hazards models were used, with multivariable adjustment for age, sex, stage, treatment, and comorbidities; analyses were stratified into localized/regional (stages I–III) and advanced/metastatic (stage IV) disease.
## Limitations
- The paper states that exposure ascertainment from the EMR and questionnaire is subject to measurement error, recall bias, inaccuracies in records, and abstraction errors.
- It notes possible selection bias because DBBR participation was voluntary, and limited generalizability because most patients were White and treated at a comprehensive cancer center.
- The paper also states that lack of post-diagnostic information (for example, weight change, smoking cessation, physical activity, diet, and medications) may have caused residual confounding.
- Evident from the text: some exposure data were available only for subsets of participants, including physical activity for 173 participants and dietary analysis restricted to localized/regional tumors, which limits precision and completeness.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
1 Valid · 1 Not valid · 9 Not checked · 33 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, pre-diagnostic MVPA did correlate with improved cancer-specific survival (HR = 0.41, p = 0.04), among patients with localized/regional tumors.”
§ Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center > 4. Discussion
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BMI at diagnosis, history of alcohol consumption, medication use, and pre-diagnostic MVPA were not associated with OS.”
- Also stated in: § 4. Discussion · plain
“Consistent with results of prior studies, stage and treatment were strong prognostic factors in our analyses, while alcohol consumption was not associated with survival [12,13,16,18,19].”
§ Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center > 3. Results > 3.2. Localized/Regional Tumors
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 4. Discussion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, no survival associations were identified for modifiable lifestyle exposures such as smoking, alcohol consumption, BMI at diagnosis, and physical activity, or for use of anti-reflux medications.”
§ Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center > 3. Results > 3.3. Advanced/Metastatic Tumors
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Among patients with stage IV disease, individuals reporting pre-diagnostic use of statins (HR = 0.62 [0.42–0.92], p = 0.018) or NSAIDs (HR = 0.61 [0.42–0.91], p = 0.016) had improved overall survival.”
- Also stated in: § 3.3. Advanced/Metastatic Tumors · plain
“Interestingly, patients reporting pre-diagnostic use of statins had a 38% reduced risk of all-cause mortality compared to statin non-users (HR = 0.62 [0.42–0.92], p = 0.018).”
- Also stated in: § 4. Discussion · plain
“By contrast, among patients with stage IV tumors, pre-diagnostic use of statins or NSAIDs was associated with increased overall and cancer-specific survival.”
§ Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center > Abstract > Abstract Purpose: The incidence of esophageal adenocarcinoma (EAC) has risen substantially in recent decades, while the average 5-year survival remains only ~20%. Disease stage and treatment are the strongest prognostic factors. The role of lifestyle factors in relation to survival remains uncertain, with a handful of studies to date investigating associations with obesity, smoking, physical activity, diet, or medications. Methods: This study included patients diagnosed with primary adenocarcinoma of the esophagus, gastroesophageal junction, or cardia (N = 371) at Roswell Park Comprehensive Cancer Center between 2003 and 2019. Leveraging extensive data abstracted from electronic medical records, epidemiologic questionnaires, and a tumor registry, we analyzed clinical, behavioral, and environmental exposures and evaluated stage-specific associations with survival. Survival distributions were visualized using Kaplan–Meier curves. Cox proportional hazards regression models adjusted for age, sex, stage, treatment, and comorbidities were used to estimate the association between each exposure and all-cause or cancer-specific mortality. Results: Among patients presenting with localized/regional tumors (stages I–III), current smoking was associated with increased overall mortality risk (HR = 2.5 [1.42–4.53], p = 0.002), while current physical activity was linked to reduced risk (HR = 0.58 [0.35–0.96], p = 0.035). Among patients with stage IV disease, individuals reporting pre-diagnostic use of statins (HR = 0.62 [0.42–0.92], p = 0.018) or NSAIDs (HR = 0.61 [0.42–0.91], p = 0.016) had improved overall survival. Exploratory analyses suggested that high pre-diagnostic dietary consumption of broccoli, carrots, and fiber correlated with prolonged overall survival in patients with localized/regional disease. Conclusion: Our data suggest that lifestyle exposures may be differentially associated with EAC survival based on disease stage. Future investigation of larger, diverse patient cohorts is essential to validate these findings. Our results may help inform the development of lifestyle-based interventions to improve EAC prognosis and quality of life.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.3. Advanced/Metastatic Tumors · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similar results were obtained when analyzing cancer-specific mortality (Table S5).”
- Also stated in: § 4. Discussion · plain
“By contrast, among patients with stage IV tumors, pre-diagnostic use of statins or NSAIDs was associated with increased overall and cancer-specific survival.”
§ Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center > 3. Results > 3.3. Advanced/Metastatic Tumors
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 4. Discussion · plain
20 more claims
Create a free account to see all 44 claims and to verify the 25 references still open.
- Probably not a substantial claim. 9
- The quote only partly states this claim. 7
- It may state two separate claims as one. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increasing number of studies have shown that low to moderate-intensity exercises could help cancer patients to recover, deal with treatment, and also have an impact on extending survival time [2,3,4,5].”
From The Effect of Vinyasa Yoga Practice on the Well-Being of Breast-Cancer Patients during COVID-19 Pandemic (2023) · cites this paper as [3]
Experimental — accuracy not yet measured
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · cited 1×
“REDCap is a secure, web-based software platform designed to support data capture for research studies [59].”
MethodPennathur, A., Gibson, M. K., Jobe, B. A., & Luketich, J. D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60643-6 · Cited by 2,390 · cited 1×
“Esophageal cancer, a relatively rare yet lethal malignancy, has a dismal average 5-year survival rate of only ~20% [1].”
BackgroundSjoquist, K. M., Burmeister, B. H., Smithers, B. M., Zalcberg, J. R., Simes, R. J., Barbour, A., & Gebski, V. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70142-5 · Cited by 1,647 · cited 1×
“Neoadjuvant therapy prior to surgery has become the standard-of-care for resectable tumors, providing a significant survival advantage relative to surgery alone [14,15].”
BackgroundUSDA National Nutrient Database for Standard Reference, Release 22
(2018) · Cited by 1,285
Smyth, E. C., Lagergren, J., Fitzgerald, R. C., Lordick, F., Shah, M. A., Lagergren, P., & Cunningham, D. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.48 · Cited by 1,012
Mechanisms linking physical activity with cancer
McTiernan, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2325 · Cited by 744 · cited 1×
“Biological mechanisms underlying associations between PA and cancer survival are under active investigation and may include reduced chronic inflammation and improved insulin sensitivity, metabolic function, and immune surveillance [25,40,41].”
BackgroundFriedenreich, C. M., Ryder‐Burbidge, C., & McNeil, J. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12772 · Cited by 661 · cited 1×
“Biological mechanisms underlying associations between PA and cancer survival are under active investigation and may include reduced chronic inflammation and improved insulin sensitivity, metabolic function, and immune surveillance [25,40,41].”
BackgroundBody Mass Index and Risk of Adenocarcinomas of the Esophagus and Gastric Cardia
Chow, W.-H., Blot, W. J., Vaughan, T. L., Risch, H. A., Gammon, M. D., Stanford, J. L., Dubrow, R., Schoenberg, J. B., Mayne, S. T., Farrow, D. C., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.2.150 · Cited by 626 · cited 3×
“Gastroesophageal reflux (GERD), central obesity, smoking, male sex, and inherited genetics are established risk factors for EAC and its precursor, Barrett’s esophagus (BE) [5–9].”
BackgroundThe Epidemiology of Esophageal Adenocarcinoma
Coleman, H. G., Xie, S.-H., & Lagergren, J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.07.046 · Cited by 549
Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005
Cook, M. B., Chow, W.-H., & Devesa, S. S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605246 · Cited by 366
Njei, B., McCarty, T. R., & Birk, J. W. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13289 · Cited by 351 · cited 1×
“Mortality is higher among older men [10], and among Blacks as compared to Whites [11].”
BackgroundCook, M. B., Kamangar, F., Whiteman, D. C., Freedman, N. D., Gammon, M. D., Bernstein, L., Brown, L. M., Risch, H. A., Ye, W., Sharp, L., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq289 · Cited by 316 · cited 1×
“Smoking is a well-established EAC risk factor [38].”
BackgroundEsomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
Jankowski, J. A. Z., de Caestecker, J., Love, S. B., Reilly, G., Watson, P., Sanders, S., Ang, Y., Morris, D., Bhandari, P., Brooks, C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31388-6 · Cited by 266
Smoking at diagnosis and survival in cancer patients
Warren, G. W., Kasza, K. A., Reid, M. E., Cummings, K. M., & Marshall, J. R. (2013) · International Journal of Cancer · doi:10.1002/ijc.27617 · Cited by 265 · cited 1×
“Several studies have shown that smoking is associated with increased mortality among cancer patients, including a large study of >5000 patients, encompassing a wide range of malignancies [39].”
BackgroundAmbrosone, C. B., Zirpoli, G. R., Hutson, A. D., McCann, W. E., McCann, S. E., Barlow, W. E., Kelly, K. M., Cannioto, R., Sucheston-Campbell, L. E., Hershman, D. L., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01203 · Cited by 246
Self-citationVITamins And Lifestyle Cohort Study: Study Design and Characteristics of Supplement Users
White, E. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh010 · Cited by 234 · cited 1×
“The DBBR questionnaire was adapted from validated questionnaires including the VITamins And Lifestyle cohort study (VITAL) [32,33] and The Diet, Exercise, Lifestyle and Cancer Prognosis Study (DELCaP) [34–36].”
MethodVaughan, T. L., Dong, L. M., Blount, P. L., Ayub, K., Odze, R. D., Sanchez, C. A., Rabinovitch, P. S., & Reid, B. J. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70431-9 · Cited by 218
Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion
Wong, R. S. Y. (2019) · Advances in Pharmacological Sciences · doi:10.1155/2019/3418975 · Cited by 211 · cited 1×
“NSAIDs including aspirin are anti-inflammatory drugs that inhibit COX enzymes, reducing cytokine/chemokine production and cell proliferation [47].”
BackgroundSurvival after surgery for oesophageal cancer: A population-based study
Rouvelas, I., Zeng, W., Lindblad, M., Viklund, P., Ye, W., & Lagergren, J. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70347-8 · Cited by 200 · cited 2×
“Disease stage and treatment are the strongest known prognostic factors [12,13].”
BackgroundResultFiber Intake and Survival After Colorectal Cancer Diagnosis
Song, M., Wu, K., Meyerhardt, J. A., Ogino, S., Wang, M., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3684 · Cited by 197 · cited 2×
“Dietary fiber may reduce pro-inflammatory cytokines in the tumor microenvironment; improve insulin sensitivity, lipid metabolism, and endothelial function; produce gastrointestinal butyrate which modulates the immune response [58].”
BackgroundCannioto, R. A., Hutson, A., Dighe, S., McCann, W., McCann, S. E., Zirpoli, G. R., Barlow, W., Kelly, K. M., DeNysschen, C. A., Hershman, D. L., et al. (2021) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djaa046 · Cited by 188
Self-citationGharahkhani, P., Fitzgerald, R. C., Vaughan, T. L., Palles, C., Gockel, I., Tomlinson, I., Buas, M. F., May, A., Gerges, C., Anders, M., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30240-6 · Cited by 186
Self-citationPeters, Y., Al‐Kaabi, A., Shaheen, N. J., Chak, A., Blum, A. E., Souza, R. F., di Pietro, M., Iyer, P. G., Pech, O., Fitzgerald, R. C., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0086-z · Cited by 175
Esophageal cancer: staging system and guidelines for staging and treatment.
Berry, M. F. (2014) · PubMed · doi:10.3978/j.issn.2072-1439.2014.03.11 · Cited by 161 · cited 1×
“Cases were further classified as ‘localized/regional’ (stages I, II, III) or ‘advanced/metastatic’ (stage IV) [29,30].”
BackgroundZhang, S. S., Yang, H., Luo, K. J., Huang, Q. Y., Chen, J. Y., Yang, F., Cai, X. L., Xie, X., Liu, Q. W., Bella, A. E., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.666 · Cited by 147 · cited 2×
“Others have reported that a higher BMI at diagnosis was associated with improved survival [18,19,22].”
BackgroundSatia-Abouta, J. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg039 · Cited by 146 · cited 1×
“The DBBR questionnaire was adapted from validated questionnaires including the VITamins And Lifestyle cohort study (VITAL) [32,33] and The Diet, Exercise, Lifestyle and Cancer Prognosis Study (DELCaP) [34–36].”
MethodIntake of Cruciferous Vegetables Modifies Bladder Cancer Survival
Tang, L., Zirpoli, G., Guru, K. A., Moysich, K. B., Zhang, Y., Ambrosone, C. B., & McCann, S. E. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0008 · Cited by 122 · cited 2×
“Intake of cruciferous vegetables such as broccoli has been linked to improved survival among bladder and breast cancer patients [55,56].”
BackgroundSelf-citationThe Innovative Potential of Statins in Cancer: New Targets for New Therapies
Di Bello, E., Zwergel, C., Mai, A., & Valente, S. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00516 · Cited by 105
Petrick, J. L., Steck, S. E., Bradshaw, P. T., Trivers, K. F., Abrahamson, P. E., Engel, L. S., He, K., Chow, W.-H., Mayne, S. T., Risch, H. A., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.25 · Cited by 91 · cited 1×
“Similar to a small number of prior studies, we did not find evidence of survival associations with dietary macronutrients such as sugar and carbohydrates [26,53,54].”
ResultThe effect of statins on survival in patients with stage IV lung cancer
Lin, J. J., Ezer, N., Sigel, K. M., Mhango, G., & Wisnivesky, J. P. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.07.006 · Cited by 86
NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis
Zhao, X., Xu, Z., & Li, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-01644-0 · Cited by 85 · cited 1×
“Pre-diagnostic NSAID use has also been linked to lower risk of metastasis in other cancers such as breast and prostate [49].”
BackgroundDemographic and lifestyle predictors of survival in patients with esophageal or gastric cancers
Trivers, K. F., de Roos, A. J., Gammon, M. D., Vaughan, T. L., RISCH, H., Olshan, A. F., SCHOENBERG, J., Mayne, S. T., Dubrow, R., Stanford, J. L., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00613-5 · Cited by 77 · cited 10×
“Cox proportional hazards (CPH) regression models were used to estimate the associations between clinical and lifestyle exposures and OS or CSS. Hazard ratios (HRs) with corresponding 95% confidence intervals (CIs) were obtained from models adjusted for age, sex, stage, treatment, and comorbidities.”
BackgroundResultInfluentialSundelöf, M., Lagergren, J., & Ye, W. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.04.002 · Cited by 75 · cited 11×
“A survival advantage was recently identified for physically active esophageal cancer patients [25], but was not reported in previous EAC-specific analyses [12,18].”
BackgroundResultInfluentialUse of Statin Medications and Risk of Esophageal Adenocarcinoma in Persons with Barrett's Esophagus
Kantor, E. D., Onstad, L., Blount, P. L., Reid, B. J., & Vaughan, T. L. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1014 · Cited by 54 · cited 1×
“Statins exert both antiproliferative and pro-apoptotic effects and may hinder neoplastic progression through multiple mechanisms, including increased ER stress, mTOR inhibition, caspase induction, and NF-kB blockade [43,50].”
BackgroundBuas, M. F., He, Q., Johnson, L., Onstad, L., Levine, D., Thrift, A. P., Gharahkhani, P., Palles, C., Lagergren, J., Fitzgerald, R. C., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-311622 · Cited by 54
Self-citationAlexandre, L., Clark, A., Bhutta, H. Y., Chan, S. S. M., Lewis, M. P., & Hart, A. R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.039 · Cited by 51
Zhu, Y., Yang, S. R., Wang, P. P., Savas, S., Wish, T., Zhao, J., Green, R., Woods, M., Sun, Z., Roebothan, B., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.6 · Cited by 49 · cited 1×
“Similar to findings reported for colorectal cancer [37], smoking was not associated with higher mortality among patients with advanced stage disease, most of whom have poor outcomes and limited survival.”
ResultLee, Y. Y., & McColl, K. E. L. (2015) · Diseases of the Esophagus · doi:10.1111/dote.12202 · Cited by 45 · cited 3×
“Gastroesophageal reflux (GERD), central obesity, smoking, male sex, and inherited genetics are established risk factors for EAC and its precursor, Barrett’s esophagus (BE) [5–9].”
BackgroundFarvid, M. S., Holmes, M. D., Chen, W. Y., ROSNER, B. A., Tamimi, R. M., Willett, W. C., & Eliassen, A. H. (2020) · Cancer Research · doi:10.1158/0008-5472.can-18-3515 · Cited by 45 · cited 1×
“Intake of cruciferous vegetables such as broccoli has been linked to improved survival among bladder and breast cancer patients [55,56].”
BackgroundDietary factors and risk of mortality among patients with esophageal cancer: a systematic review
Sun, L. L., Yan, L., Liu, Z., Zhao, W., Zhang, C., Chen, Y.-M., Lao, X. Q., & Liu, X. (2020) · BMC Cancer · doi:10.1186/s12885-020-06767-8 · Cited by 37 · cited 2×
“Diet, another important modifiable lifestyle factor, has not been intensively investigated in relation to EAC outcomes [26].”
BackgroundResultSelf-citationConditional Survival of Esophageal Cancer An Analysis from the SEER Registry (1988–2011)
Kim, E., Koroukian, S. M., & Thomas, C. R. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000649 · Cited by 35 · cited 1×
“Mortality is higher among older men [10], and among Blacks as compared to Whites [11].”
BackgroundJayedi, A., Emadi, A., Khan, T. A., Abdolshahi, A., & Shab‐Bidar, S. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1803928 · Cited by 35
Li, N., Petrick, J. L., Steck, S. E., Bradshaw, P. T., McClain, K. M., Niehoff, N. M., Engel, L. S., Shaheen, N. J., Risch, H. A., Vaughan, T. L., et al. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx203 · Cited by 33 · cited 1×
“Similar to a small number of prior studies, we did not find evidence of survival associations with dietary macronutrients such as sugar and carbohydrates [26,53,54].”
ResultCannioto, R. A., Dighe, S. G., Mahoney, M. C., Moysich, K. B., Sen, A., Hulme, K., McCann, S. E., & Ambrosone, C. B. (2018) · Cancer Causes & Control · doi:10.1007/s10552-018-1101-5 · Cited by 31
Self-citationWenker, T. N., Khan, A., Liu, Y., El‐Serag, H. B., & Thrift, A. P. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0169-6 · Cited by 30 · cited 2×
“Post-diagnostic use has also been linked to improved survival in EAC [27,28,46], but associations with pre-diagnostic use have not been reported [12,18,19].”
BackgroundThrift, A. P., Nagle, C. M., Fahey, P. P., Smithers, B. M., Watson, D. I., & Whiteman, D. C. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9913-1 · Cited by 29
van Staalduinen, J., Frouws, M. A., Reimers, M. S., Bastiaannet, E., van Herk‐Sukel, M. P. P., Lemmens, V. E. P. P., de Steur, W. O., Hartgrink, H. H., van de Velde, C. J. �., & Liefers, G. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.65 · Cited by 28 · cited 1×
“Post-diagnostic use has also been linked to improved survival in EAC [27,28,46], but associations with pre-diagnostic use have not been reported [12,18,19].”
BackgroundMcCain, R. S., McManus, D. T., McQuaid, S., James, J. A., Salto-Tellez, M., Reid, N. B., Craig, S., Chisambo, C., Bingham, V., McCarron, E., et al. (2020) · Cancer Causes & Control · doi:10.1007/s10552-019-01247-2 · Cited by 28 · cited 5×
“Cox proportional hazards (CPH) regression models were used to estimate the associations between clinical and lifestyle exposures and OS or CSS. Hazard ratios (HRs) with corresponding 95% confidence intervals (CIs) were obtained from models adjusted for age, sex, stage, treatment, and comorbidities.”
BackgroundResultInfluentialMadani, K., Zhao, R., Lim, H. J., Casson, S. M., & Casson, A. G. (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.03.054 · Cited by 22 · cited 2×
“Consistent with some prior studies [12,23], we did not find an association between BMI at diagnosis and OS.”
BackgroundResultNSAID use and somatic exomic mutations in Barrett’s esophagus
Galipeau, P. C., Oman, K. M., Paulson, T. G., Sanchez, C. A., Zhang, Q., Marty, J. A., Delrow, J. J., Kuhner, M. K., Vaughan, T. L., Reid, B. J., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0520-y · Cited by 21 · cited 1×
“Genomic studies of patients with BE have demonstrated lower levels of somatic chromosome alterations among NSAID users versus non-users, suggesting potential beneficial effects on genome integrity [48].”
BackgroundEarly adulthood body mass index, cumulative smoking, and esophageal adenocarcinoma survival
Spreafico, A., Coate, L., Zhai, R., Xu, W., Chen, Z.-F., Chen, Z., Patel, D., Tse, B., Brown, M. C., Heist, R. S., et al. (2017) · Cancer Epidemiology · doi:10.1016/j.canep.2016.11.009 · Cited by 19 · cited 3×
“Mechanisms underlying a potential positive or negative role for obesity in EAC prognosis remain poorly understood but may be linked to improved nutritional status or increased systemic inflammation, respectively [17].”
BackgroundResultDighe, S. G., Chen, J., Yan, L., He, Q., Gharahkhani, P., Onstad, L., Levine, D., Palles, C., Ye, W., Gammon, M. D., et al. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa132 · Cited by 14
Self-citationLoomans-Kropp, H. A., Chaloux, M., Richmond, E. S., & Umar, A. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0274 · Cited by 13
Corpo, M. D., Schlottmann, F., Strassle, P. D., Nurczyk, K., & Patti, M. G. (2019) · Journal of Laparoendoscopic & Advanced Surgical Techniques · doi:10.1089/lap.2019.0350 · Cited by 10 · cited 1×
“Neoadjuvant therapy prior to surgery has become the standard-of-care for resectable tumors, providing a significant survival advantage relative to surgery alone [14,15].”
BackgroundLuc, L., Baumgart, C., Weiss, E. H., Georger, L. A., Ambrosone, C. B., Zirpoli, G., & McCann, S. E. (2014) · Public Health Nutrition · doi:10.1017/s1368980014001062 · Cited by 9
Self-citationPrediagnostic adult body mass index change and esophageal adenocarcinoma survival
Loehrer, E. A., Giovannucci, E. L., Betensky, R. A., Shafer, A., & Christiani, D. C. (2020) · Cancer Medicine · doi:10.1002/cam4.3015 · Cited by 9 · cited 1×
“In contrast to two earlier reports, we also found no association between self-reported past adulthood BMI and OS [17,52].”
ResultEndoscopy for gastroesophageal reflux disease and survival in esophageal adenocarcinoma
Holmberg, D., Ness‐Jensen, E., Mattsson, F., & Lagergren, J. (2019) · International Journal of Cancer · doi:10.1002/ijc.32721 · Cited by 6 · cited 1×
“Most studies have also indicated no survival associations with reflux [12,18,19], apart from a recent Scandinavian analysis reporting improved survival among symptomatic GERD patients [24].”
Result
Research works printed but not linked: 1
- Rosen, R.D., and Sapra, A. (2021, January 06). TNM Classification, StatPearls [Internet], Available online: https://www.ncbi.nlm.nih.gov/books/NBK553187/.
Cited by
Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies
Nitsche, L., Mukherjee, S., Cheruvu, K., Krabak, C., Rachala, R., Ratnakaram, K., Sharma, P., Singh, M., & Yendamuri, S. (2022) · Cancers · doi:10.3390/cancers14061440 · Cited by 53
“Statins have improved overall survival in stage four esophageal cancer patients [157].”
BackgroundSelf-citationZhou, Q., Jiao, Z., Liu, Y., Devreotes, P. N., & Zhang, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1234713 · Cited by 31
Zok, A., Matecka, M., Zapala, J., Izycki, D., & Baum, E. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043770 · Cited by 13
Gastroesophageal disease risk and inhalational exposure a systematic review and meta-analysis
Kim, D. H., PODURY, S., Zadeh, A. F., Mahmoodi, T., Kwon, S., Grünig, G., Liu, M., & Nolan, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-06620-7 · Cited by 10
MiR ‐671‐5p sponging activity of circMMP1 promotes esophageal squamous cancer progression
Li, R., Chai, L., Lei, L., Guo, R., & Wen, X. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.15078 · Cited by 9
“It is estimated that less than 30% of ESCC patients survive 5 years despite multidisciplinary therapy.(4) With the advent of precision medicine, revealing the pathogenesis of cancer at the molecular level and targeting therapy for patients have become an important development direction of tumor therapy.”
Background
Metadata
- Authors
- Dighe, S. G., Yan, L., Mukherjee, S., McGillicuddy, C. S., Hulme, K. L., Hochwald, S. N., Yendamuri, S., Bain, A. J., Robillard, K. T., Moysich, K. B., Ambrosone, C. B., Millen, A. E., & Buas, M. F.
- Affiliations
- Roswell Park Comprehensive Cancer Center (US)
- University at Buffalo, State University of New York (US)
- Corresponding author
- Dighe, Shruti G.
- Buas, Matthew F.
- ORCID
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2021-09-16
- Volume
- 13
- Issue
- 18
- Pages
- 4653
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC8465866
- OpenAlex
- W3200933658
- Cited by
- 8
- References
- 58
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 5 · 2022: 1
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Cancer Institute (P30CA016056)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- esophageal adenocarcinoma, gastroesophageal junction cancer, gastric cardia cancer, prognostic factors, survival, lifestyle factors, smoking, physical activity, statins, nonsteroidal anti-inflammatory drugs, dietary fiber, broccoli, carrot, disease stage, cancer-specific mortality, all-cause mortality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

